Abstracts tagged "Fibromyalgia and questionnaires"

Abstract Number: 72 • 2015 ACR/ARHP Annual Meeting
Performance of the New Survey Criteria for Fibromyalgia Under Conditions of Low and High Symptom Activity
Robert S. Katz and Frank Leavitt, Rush University Medical Center, Chicago, IL
Background/Purpose: In 2010, new criteria for fibromyalgia were proposed. In 2011, the questionnaire was adjusted so that patients provided the necessary information to satisfy the…
Abstract Number: 79 • 2015 ACR/ARHP Annual Meeting
Hypervigilence: Patients with Fibromyalgia Often Appear Very Sensitive to Environmental Stresses
Robert S. Katz¹, Kelli Davis², Lauren Kwan² and Jessica L. Polyak², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: We inquired about hypervigilence and hypersensitivity to various environmental stresses in patients with fibromyalgia and in rheumatic disease controls. Methods: 103 fibromyalgia patients with…
Abstract Number: 2303 • 2015 ACR/ARHP Annual Meeting
Psychometrics of Online Administration of Fibromyalgia Impact Questionnaire – Revised
Scott M. Mist¹ and Kim Jones², ¹Office of Research & Development, Oregon Health & Science University, Portland, OR, ²Rsch & Develop/Mail Code SN OR, Oregon Health Sciences Univ, Portland, OR
Background/Purpose: The Fibromyalgia Impact Questionnaire – Revised (FIQR) [1] has been in wide use since Bennett et al revised the original FIQ[2]. While the instrument…
Abstract Number: 893 • 2014 ACR/ARHP Annual Meeting
Polysymptomatic Distress Categories for Clinical and Research Use
Frederick Wolfe¹, Brian T. Walitt², Johannes Rasker³, Robert S. Katz⁴ and Winfried Häuser⁵, ¹National Data Bank for Rheumatic Diseases, Wichita, KS, ²Rheumatology, Washington Hospital Center, Washington, DC, ³Dpt. Psychology, Health and Technology, University Twente, Enschede, Netherlands, ⁴Rush Medical College, Chicago, IL, ⁵Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: The polysymptomatic distress (PSD) scale is derived from variables used in the 2010 American College of Rheumatology (ACR) fibromyalgia (FM) criteria as modified for…
Abstract Number: 1880 • 2012 ACR/ARHP Annual Meeting
A Brazilian Portuguese Validation of the Revised Fibromyalgia Impact Questionnaire (FIQR)
Eduardo S. Paiva¹, Roberto E. Heymann², Marcelo C. Rezende³, Milton Helfenstein Jr.⁴, José E. Martinez⁵, José R. Provenza⁶, Aline Ranzolin⁷, Marcos Renato Assis⁸, Vivian D. Pasqualin⁹ and Robert M. Bennett¹⁰, ¹Rheumatology, Universidade Federal do Paraná, Curitiba, Brazil, ²Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, ³Rheumatology, Santa Casa de Campo Grande, Campo Grande, Brazil, ⁴Rheumatology, Universidade Federal de de São Paulo, São Paulo, Brazil, ⁵Rheumatology, Pontifícia Universidade Católica de São Paulo, Sorocaba, Brazil, ⁶Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, ⁷Universidade Federal de Pernambuco, Recife PE, Brazil, ⁸Faculdade de Medicina de Marilia, Marilia, Brazil, ⁹Pontifícia Universidade Católica do Paraná, Curitiba, Brazil, ¹⁰Medicine & Nursing, Oregon Health & Science Univ, Portland, OR
Background/Purpose: General health evaluation questionnaires are important instruments in assessing the impact of disorders that affect multiple domains of a patient´s life. The Fibromyalgia Impact Questionnaire…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].